Innospera Pharma
Innospera Pharma is a Healthcare & Life Sciences startup based in Canada, most recent round Series A, 1 tracked investor.
About Innospera Pharma
Innospera Pharma is a company headquartered in Canada. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Innospera Pharma is a clinical-stage biotechnology company developing small-molecule PPAR potentiators for treating chronic inflammatory, fibrotic, and metabolic diseases, with a leading product targeting idiopathic pulmonary fibrosis (IPF). Their approach involves restoring PPAR signaling to reduce inflammation and fibrosis with improved safety and tolerability.
Explore Innospera Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.